711 filings
Page 27 of 36
3
iwmtnto6
15 Sep 17
KEMPHARM / ANDREW G BLUHM ownership change
12:00am
4
ct2217v
15 Sep 17
KEMPHARM / ANDREW G BLUHM ownership change
12:00am
8-K
zlhobi5 v4
12 Sep 17
KemPharm Announces FDRR Process Completion and Resubmission of the Apadaz™ NDA
12:00am
4
m9q hb2kp
25 Aug 17
KEMPHARM / Daniel L Cohen ownership change
12:00am
4
vg8 jkfnffz
25 Aug 17
KEMPHARM / Gordon K Johnson ownership change
12:00am
8-K
mgrgo
10 Aug 17
KemPharm Announces Preliminary Results from KP415 Pharmacokinetic Single and Multiple Dose Trial
12:00am
8-K
caswwxprnrtil59pnmf
10 Aug 17
KemPharm, Inc. Reports Second Quarter 2017 Results
12:00am
8-K
qgxqrguz5exe6e
28 Jun 17
KemPharm Strengthens ADHD Prodrug Pipeline with Development of KP484, A New, Super-Extended Release ADHD Methylphenidate Product Candidate
12:00am
4
0izpe6 23jhru2f
21 Jun 17
KEMPHARM / Travis C Mickle ownership change
12:00am
4
whlan ol1c
21 Jun 17
KEMPHARM / R. LaDuane Clifton ownership change
12:00am
4
ib7z2utbk xr8r
26 May 17
KEMPHARM / Daniel L Cohen ownership change
12:00am
4
h12h9z6vm jq
24 May 17
KEMPHARM / Richard W Pascoe ownership change
12:00am
4
mhni8 ib40a33
24 May 17
KEMPHARM / Joseph Saluri ownership change
12:00am
4
3fvd800nr54jnd4
24 May 17
KEMPHARM / David S Tierney ownership change
12:00am
4
aap31pzupyyxm79
24 May 17
KEMPHARM / Matthew R Plooster ownership change
12:00am
4
vm8fk14gjxlvzyfk 4i
24 May 17
KEMPHARM / Danny L Thompson ownership change
12:00am
8-K/A
8ax5sggx3w hjogn3d
23 May 17
KemPharm, Inc. Reports First Quarter 2017 Results
12:00am
8-K
5hmx3tgaxskgo
23 May 17
Submission of Matters to a Vote of Security Holders
12:00am